Signature Care Oil Free Acne Wash Pink Grapefruit Foaming Scrub

Description

Signature Care Oil-Free Acne Wash Pink Grapefruit Foaming Scrub is presented in a dosage form of a foaming scrub, contained in a 6.7 fluid ounce (198 mL) bottle. The product is identified by the National Drug Code (NDC) 21130-734-15.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic or nonteratogenic effects associated with this medication.

Dosage and Administration

The affected area should be covered with a thin layer of the medication and rinsed thoroughly. Initial treatment should begin with one application per day. Based on the patient's response and as directed by a healthcare professional, the frequency may be gradually increased to two or three times daily.

It is important to monitor for signs of excessive drying of the skin. If bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day to mitigate these effects.

Contraindications

Use of this product is contraindicated in individuals with a history of eye contact. In the event of contact with the eyes, it is imperative to flush thoroughly with water. No other contraindications have been identified.

Warnings and Precautions

For external use only. It is imperative that healthcare professionals advise patients to adhere strictly to this guideline to prevent unintended systemic exposure.

Skin irritation and dryness may be exacerbated when this product is used concurrently with other topical acne medications. Therefore, it is recommended that only one topical acne treatment be utilized at a time to minimize the risk of irritation. Patients should be monitored for signs of skin irritation, and if such symptoms arise, they should discontinue use of all topical acne medications and consult their healthcare provider.

Healthcare professionals should instruct patients to avoid contact with the eyes. In the event of accidental contact, patients should be advised to flush the affected area thoroughly with water to mitigate potential irritation.

In cases of ingestion, immediate medical assistance should be sought. Patients should be instructed to contact a Poison Control Center or seek emergency medical help without delay.

No specific recommendations for discontinuation of use have been provided in the insert; however, healthcare providers should remain vigilant and assess the patient's response to treatment regularly.

Side Effects

For external use only. No specific adverse reactions or side effects have been reported in the clinical trial data or postmarketing experience. Patients and participants should be advised to use the product as directed and to monitor for any unexpected reactions.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications is recommended to alleviate symptoms. Monitoring for signs of skin irritation is essential when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Signature Care Oil Free Acne Wash Pink Grapefruit Foaming Scrub (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The product contains salicylic acid, which is generally contraindicated in pregnancy due to potential risks to the fetus. While specific data regarding the use of this product during pregnancy is not provided, caution is advised when considering its use in pregnant patients. There are no specific dosage modifications indicated for pregnant individuals. It is recommended that women of childbearing potential consult a healthcare provider prior to using this product to discuss potential risks and benefits.

Lactation

There are no specific warnings or considerations regarding nursing mothers or lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this medication in lactating mothers without specific concerns related to breastfeeding. However, as with any medication, it is advisable to monitor breastfed infants for any potential effects.

Renal Impairment

There is no specific information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution when prescribing to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and consider the potential implications of excessive dosing.

It is essential to monitor patients closely for any signs or symptoms that may arise from an overdosage scenario. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of suspected overdosage, immediate medical attention should be sought. Healthcare providers should implement standard supportive measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

For further management, consultation with a poison control center or a medical toxicologist is recommended to guide appropriate interventions based on the clinical presentation and specific circumstances of the overdosage.

Documentation of the incident, including the amount ingested and the time of exposure, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to seek immediate medical assistance or contact a Poison Control Center if the medication is swallowed.

It is important to inform patients that the use of this medication in conjunction with other topical acne treatments may increase the likelihood of skin irritation and dryness. Therefore, if patients experience irritation, they should be instructed to limit their use to one topical acne medication at a time.

Patients should also be cautioned to avoid contact with the eyes. In the event of accidental contact, they should be directed to flush the eyes thoroughly with water to minimize any potential irritation.

Storage and Handling

The product is supplied in configurations that may include various packaging options. It is important to note that the product has the potential to stain certain fabrics, and appropriate precautions should be taken during handling to prevent any unintended damage.

For optimal storage, the product should be kept in a controlled environment, away from direct sunlight and extreme temperatures. Specific temperature ranges for storage have not been provided; however, it is advisable to maintain a stable and moderate climate to ensure product integrity.

Care should be taken to handle the product with clean, dry hands or appropriate gloves to minimize the risk of staining and to maintain the quality of the product.

Additional Clinical Information

The route of administration for the medication is topical. Patients should apply a thin layer to the entire affected area and rinse thoroughly one to three times daily. It is recommended to start with one application daily, gradually increasing to two or three times daily as needed or directed by a clinician. If patients experience bothersome dryness or peeling, they should reduce the application frequency to once a day or every other day.

Clinicians should counsel patients on the potential for skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised to use only one topical acne medication at a time to minimize irritation. Patients should avoid contact with the eyes; in case of contact, they should flush thoroughly with water. Additionally, the medication should be kept out of reach of children, and if swallowed, medical assistance or contact with a Poison Control Center should be sought immediately.

Drug Information (PDF)

This file contains official product information for Signature Care Oil Free Acne Wash Pink Grapefruit Foaming Scrub, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)